CD36 and neoplasm: Multicolor IF analysis revealed elevated expression of key enzymes associated with glucose and lipid metabolism (GLUT1 for glucose transport; FASN for fatty acid synthesis; CD36 and FABPs for fatty acid transport) in resistant tumor tissues compared with parental cells, which was unaffected by lenvatinib treatment, indicating metabolic reprogramming in resistant tumors (Fig. 1e, f).